VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ASCO 2020 | Assessing MRD in multiple myeloma

Sham Mailankody, MBBS, Memorial Sloan Kettering Cancer Center, New York City, NY, discusses MRD assessment in multiple myeloma (MM). Specifically, Dr Mailankody outlines bone marrow MRD testing, assessed by next-generation flow-cytometry and alternative methods of disease evaluation in serum, such as mass spectrometry. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter